Table 2.
Clinical variables and mood-stabilizing treatment of participants with BD.
| Individuals with BD (n = 48) | ||||
|---|---|---|---|---|
| Diagnosis | Bipolar I: 72.9% Bipolar II: 27.1% |
|||
| Years of illness (Mean ± SD) | 20.82 (±9.72) | |||
| Number of depressions (Mean ± SD) | 6.42 (±9.59) | |||
| - Mild | 4.71 (±4.66) | |||
| - Moderate | 4.87 (±8.93) | |||
| - Severe | 1.56 (±2.03) | |||
| Number of manic episodes (Mean ± SD) | 6.78 (±10.19) | |||
| - Hypomanic | 3.42 (±6.10) | |||
| - Moderate manic | 2.38 (±4.74) | |||
| - Severe manic | 1.13 (±1.85) | |||
| CGI (Mean ± SD) | 2.53 (±0.91) | |||
| HAMD (Mean ± SD) | 4.11 (±3.86) | |||
| YMRS (Mean ± SD) | 1.68 (±2.49) | |||
| HAMA (Mean ± SD) | 6.21 (±5.14) | |||
| Alda Score | ||||
| Lithium | Valproate | Lamotrigine | ||
| Current prophylactic treatment (n, %) | 44 (91.66%) | |||
| - only lithium | 8 (16.67%) | 2.75 (±2.76) | ||
| - only anticonvulsant | 11 (22.92%) | |||
| - only valproate | 8 (16.67)% | 4.00 (±0.82) | ||
| - only lamotrigine | 2 (4.17%) | 1.00 (±1.41) | ||
| - only antipsychotic | 3 (6.25%) | |||
| - lithium + anticonvulsant | 7 (14.58%) | 3.86 (±2.79) | ||
| - with valproate | 3 (6.25%) | 3.67 (±3.21) | 3.67 (±3.21) | |
| - with lamotrigine | 2 (4.17%) | 5.50 (±2.12) | 8 (±0) | |
| - lithium + antipsychotic | 2 (4.17%) | 0 | ||
| - anticonvulsant + antipsychotic | 10 (20.83%) | |||
| - with valproate | 7 (14.58%) | 2.86 (±2.48) | ||
| - with lamotrigine | 1 (2.08%) | 7 | ||
| Other psychopharmaceuticals (n, %) | ||||
| - Antipsychotics in subprophylactic dose (n = 44) | 17 (38.64%) | |||
| - Antidepressants (n = 44) | 11 (25.00%) | |||
| - Benzodiazepines (n = 44) | 23 (52.27%) | |||
Note. Abbr.: BD = bipolar disorder; CGI = Clinical Global Impression; HAMA = Hamilton Rating Scale for Anxiety; HAMD = Hamilton Rating Scale for Depression; SD = standard deviation; YMRS = Young Mania Rating Scale.